New Balance settles shoe patent claim
Sports footwear company New Balance has settled its patent infringement row with US-based Acme IP Holdings.
Acme filed its claim against New Balance in October last year at the US District Court for the Northern District of Illinois, Eastern Division.
New Balance allegedly infringed two patents, US numbers 5,343,445 and 5,452,269, titled “Athletic shoe with timing device”.
According to the suit, the footwear company infringed the patents between 2010 and 2013 through the sale of the New Balance N8 trainer kit.
The patents expired in 2013.
In March, New Balance counterclaimed against Acme, seeking protection under North Carolina’s Abusive Patent Assertions Act and claiming that Acme had made a bad-faith assertion of patent infringement.
On Monday, May 8, Judge John Tharp signed a stipulation of dismissal.
Acme’s claims, and New Balance’s counterclaims, were dismissed with prejudice, and each party bore its own costs and attorneys’ fees.
Join us for a FREE webinar - The Halo effect: walking the wilfulness tightrope - on May 16
Today’s top stories
Federal Circuit affirms invalidation of AT&T patent
Liverpool FC launches cheaper shirt in China
Defend Trade Secrets Act turns one year old
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk